Vertex Pharmaceuticals
VRTX
#144
Rank
NZ$213.95 B
Marketcap
$833.18
Share price
1.82%
Change (1 day)
22.18%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): NZ$0.56 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$11.02 Billion. a decrease over its 2023 earnings that were of NZ$7.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.48 B-93.69%
2023 NZ$7.67 B3.19%
2022 NZ$7.43 B53.56%
2021 NZ$4.84 B-12.06%
2020 NZ$5.50 B118.45%
2019 NZ$2.52 B120.64%
2018 NZ$1.14 B1473.64%
2017 NZ$72.61 M197.6%
2016 NZ$24.39 M-102.97%
2015 -NZ$0.83 Billion-28.46%
2014 -NZ$1.15 Billion-51.5%
2013 -NZ$2.37 Billion-30584.68%
2012 NZ$7.76 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.03 Billion
2007 -NZ$0.72 Billion83.1%
2006 -NZ$0.4 Billion59.02%
2005 -NZ$0.25 Billion3.28%
2004 -NZ$0.24 Billion-38.16%
2003 -NZ$0.39 Billion
2000 -NZ$65.99 Million-20.38%
1999 -NZ$82.88 Million31.62%
1998 -NZ$62.97 Million91.05%
1997 -NZ$32.96 Million-36.24%
1996 -NZ$51.7 Million12.45%
1995 -NZ$45.97 Million27.4%
1994 -NZ$36.08 Million-1833.33%
1993 NZ$2.08 M-112.12%
1992 -NZ$17.18 Million175%
1991 -NZ$6.25 Million-12.2%
1990 -NZ$7.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.30 B-36.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.48 B 2,478.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.97 B 5,264.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.54 Billion-3,102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.25 B 6,149.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.17 Billion-134.76%๐Ÿ‡บ๐Ÿ‡ธ USA